Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-10

Clinical Trial Update: Gabapentin Treatment of Cannabis Dependence [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating gabapentin for cannabis dependence has been completed, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

Sponsor: The Scripps Research Institute | Conditions: Cannabis Dependence | Phase 2 | Status: COMPLETED | Results posted: 2017-02-10